🧬 SinoBioData Academic Portal
Open AccessDOI: 10.3724/abbs.2025207Original Research

COCA-seq: genome-wide mapping of O-GlcNAc-associated open chromatin

🇨🇳 Original Chinese Title: COCA-seq: genome-wide mapping of O-GlcNAc-associated open chromatin

Chang Ge¹,Ran Zhao¹,Hongyu Jiang¹,Qingbin Chen¹,Zhentao Yu¹,Hankai Yang¹,Xuan Jiang¹,Qile Ma¹,Lirui Han¹,Kairan Yu¹,Guofang Li¹,Huang Huang¹,Wei Wang¹,Yubo Liu¹,Qingyue Zhang¹,Xing Jin¹

College of Life and Health Sciences, Northeastern University

Read Executive PreviewQuick FAQ
COCA-seq: genome-wide mapping of O-GlcNAc-associated open chromatin
Graphical Abstract / Figure
Published In
Acta Biochimica et Biophysica Sinica
Published:2026Edition:Vol. 58, Issue 5 • pp. 975-988Citation:Chang Ge et al. (2026), Acta Biochimica et Biophysica Sinica
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Acta Biochimica et Biophysica Sinica (生物化学与生物物理学报).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • COCA-seq is a novel genome-wide method that chemoselectively profiles O-GlcNAc-associated open chromatin regions, combining DNase-seq and metabolic glycan labeling. • The method demonstrates dual fidelity in O-GlcNAc chemoselectivity and open chromatin specificity, validated across low- and high-throughput levels. • Application to doxorubicin-resistant breast cancer reveals key regulatory genes and transcription factors, integrating with RNA-seq to uncover mechanisms of drug resistance. • COCA-seq provides a versatile tool for deciphering the role of O-GlcNAcylation in chromatin accessibility and gene regulation across diverse biological contexts.
Sponsored Research Highlight

Abstract

O-GlcNAcylation, a prevalent reversible post-translational modification, intricately alters non-histone proteins, influencing the organization of gene transcriptional regulation within the accessible chromatin environment. This nucleoplasmic landscape, characterized by histone-free regions, fundamentally enables O-GlcNAc-mediated modulation through dynamic accessibility. However, unraveling the O-GlcNAc-open chromatin interplay that governs sophisticated transcriptional regulatory networks remains constrained by current techniques, which lack the resolution to probe this spatiotemporal crosstalk. Here, we report a general strategy to systematically and chemoselectively profile O-GlcNAc-associated chromatin accessibility on a genome-wide scale (COCA-seq). Through comprehensive validation across low- and high-throughput levels, we demonstrate COCA-seq’s dual fidelity in both O-GlcNAc chemoselectivity and open chromatin specificity. We employ it to delve into doxorubicin resistance for breast cancer, scrutinizing pivotal regulatory genes and transcription factors implicated in this complex biological event. By integrating bulk RNA-seq with COCA-seq, we offer a multiomics perspective, shedding light on related biological processes and pathways like drug efflux and stress homeostasis, thereby uncovering potential mechanisms by which O-GlcNAc-associated open chromatin orchestrates tumor drug resistance. COCA-seq emerges as a general and versatile tool across various biological contexts, poised to reveal the landscape of O-GlcNAc-associated open chromatin regions across the genome and decipher the significance of glycosylation behind it.

1. Introduction

Chromatin, an integral component exclusive to the nucleus of eukaryotic cells, comprises a complicated assembly of nucleic acids and histones and exists in two distinct states: closed and open. Closed chromatin ensconces DNA around histones, forming nucleosomes with minimal inter-nucleosome distances, impeding both transcription and replication processes [1]. In contrast, open chromatin, characterized by its accessibility, inclining itself to transcription factors (TFs), RNA polymerase II, etc., thus facilitating gene expression [2]. Open chromatin regions (OCRs) represent segments of chromatin in an accessible state, which contribute to protein-DNA interactions [3]. It has been reported that OCRs contain a large number of TF binding sites and exhibit dynamic histone modifications alongside diminished DNA methylation level which is crucial for modulating gene expression, introducing phenotypic alterations and steering cellular behaviors like differentiation and development [1,2,4].

O-GlcNAcylation, an essential post-translational modification (PTM) that attaches O-linked β-N-acetylglucosamine (O-GlcNAc) moieties to serine or threonine residues of proteins, is widespread across nuclear and cytoplasmic proteins, most notably non-histone proteins (NHPs) like TFs [5]. The critical regulatory roles of O-GlcNAc modification on chromatin-bound proteins and its influence on various facets of transcriptional regulation have been underscored in previous studies, encompassing the stability, transcriptional activity, interaction with chromatin, nuclear localization of NHPs [6]. Given the significant role of NHPs in gene expression regulation, deciphering the distribution of O-GlcNAc-modified NHPs within OCRs assumes paramount importance, offers insights into O-GlcNAc-associated chromatin accessibility and delineates lineage-specific transcriptional regulatory principles. High-throughput sequencing technologies such as DNase-seq and ATAC-seq have been extensively utilized to profile chromatin accessibility, enabling exploration of OCRs on a genome-wide scale across diverse biological processes [7]. However, there is still an absence of approaches that allow genome-wide enrichment of OCRs bound by O-GlcNAc-modified NHPs in the nucleus and accordingly investigation of their connections.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Chang Ge, Ran Zhao, Hongyu Jiang, Qingbin Chen, Zhentao Yu, Hankai Yang, Xuan Jiang, Qile Ma, Lirui Han, Kairan Yu, Guofang Li, Huang Huang, Wei Wang, Yubo Liu, Qingyue Zhang, Xing Jin (2026). COCA-seq: genome-wide mapping of O-GlcNAc-associated open chromatin. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025207
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is COCA-seq?

COCA-seq (Chemoselectively O-GlcNAc-associated chromatin accessibility sequencing) is a genome-wide method that integrates DNase-seq with O-GlcNAc metabolic glycan labeling to profile O-GlcNAc-associated open chromatin regions.

How does COCA-seq work?

COCA-seq combines DNase-seq for chromatin accessibility profiling with metabolic glycan labeling to chemoselectively enrich O-GlcNAc-modified non-histone proteins bound to open chromatin, enabling genome-wide mapping of these regions.

What are the key applications of COCA-seq?

COCA-seq can be used to study the role of O-GlcNAcylation in gene regulation, chromatin dynamics, and diseases such as cancer, particularly drug resistance, by integrating with other omics data like RNA-seq.

What is the significance of O-GlcNAc-associated open chromatin?

O-GlcNAc-associated open chromatin regions are accessible chromatin areas bound by O-GlcNAc-modified non-histone proteins, which are crucial for transcriptional regulation and may play a role in disease mechanisms like drug resistance.

How was COCA-seq validated?

COCA-seq was validated through comprehensive low- and high-throughput experiments, demonstrating its dual fidelity in O-GlcNAc chemoselectivity and open chromatin specificity.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF